Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-004397-96Phase 2Completed
Phase 2, open-label trial of 5-aminolevulinic acid (2 arms), sponsored by Merete Hædersdal. Primary endpoints: PpIX fluorescence intensity at skin surface and PpIX fluorescence intensity and biodistribution within skin. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-004397-96.